They have no free cash flow , cash actually decreased by $50M. At this rate they won't get pay another divvy until there is a turnaround. If you break the second halve up ( pre-impairment ) you had NPAT of $18M, EPS of 4.7c and divvy 1.5c. This a decrease of 50% of what they achieved in the 1st half of the financial year. Certainly not making this cheap. Major assets sales needed to restore a very unhealthy balance sheet.
- Forums
- ASX - By Stock
- MRM
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-8
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MRM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online